Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.
Jia JD, Hou JL, Yin YK, Tan DM, Xu D, Niu JQ, Zhou XQ, Wang YM, Zhu LM, Chen CW, He YW, Ren H, Wan MB, Wu SM, Wang QH, Wei L, Bao W, Dong Y, Trylesinski A.
Jia JD, et al. Among authors: dong y.
Hepatol Int. 2014 Jan;8(1):72-82. doi: 10.1007/s12072-013-9488-2. Epub 2013 Nov 28.
Hepatol Int. 2014.
PMID: 26202408